Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
61
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer

Bing-Lei Ma1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
,
Lin Yao1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
,
Yu Fan1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
,
Yu Wang1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
,
Yi-Sen Meng1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Qian Zhang1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
,
Zhi-Song He1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
,
Jie Jin1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
&
Li-Qun Zhou1 Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing, People’s Republic of China;2 Beijing Key Laboratory of Urogenital Diseases (male), Molecular Diagnosis and Treatment Center, Beijing, People’s Republic of China
 show all
Pages 4143-4151 | Published online: 10 May 2019

References

  • D‘Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969–974. 9749478
  • Sanda MG, Cadeddu JA, Kirkby E, et al. Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options. J Urol. 2018;199(3):990–997. doi:10.1016/j.juro.2018.01.00229331546
  • Mottet N, Bellmunt J, Briers E et al. EAU-ESTRO-ESUR-SIOG guidelines on prostate cancer. Eur Assoc Urol; 2018 Available from: http://uroweb.org/guideline/prostate-cancer.
  • NCCN clinical practice guidelines in oncology prostate cancer version 4; 2018 Available from: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 215, 2018.
  • Schulman CC, Debruyne FM, Forster G, et al. 4-year follow-up results of a European prospective randomized study on neoadjuvant hormonal therapy prior to radical prostatectomy in T2-3N0M0 prostate cancer. Eur Urol. 2000;38:706–713. doi:10.1159/00002036611111188
  • Soloway MS, Pareek K, Sharifi R, et al. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol. 2002;167:112–116. 11743286
  • Aus G, Abrahamsson PA, Ahlgren G, et al. Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial. BJU Int. 2002;90:561–566. 12230618
  • Klotz LH, Goldenberg SL, Jewett MA, et al. Long-term follow-up of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol. 2003;170(3):791–794. doi:10.1097/01.ju.0000081404.98273.fd12913699
  • Kumar S, Shelley M, Harrison C, et al. Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev. 2006;18(4):CD006019.
  • Walsh PC, Marschke PL. Intussusception of the reconstructed bladder neck leads to earlier continence after radical prostatectomy. Urology. 2002;59(6):934–938. 12031385
  • Breda G, Celia A. How to preserve potency and continence in localized prostate cancer. BJU Int. 2007;100(Suppl 2):29–31. doi:10.1111/j.1464-410X.2007.06950.x17594355
  • Walz J, Epstein JI, Ganzer R, et al. A critical analysis of the current knowledge of surgical anatomy of the prostate related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy: an update. Eur Urol. 2016;70(2):301–311. doi:10.1016/j.eururo.2016.01.02626850969
  • Rajih E, Meskawi M, Alenizi AM, et al. Perioperative predictors for post-prostatectomy urinary incontinence in prostate cancer patients following robotic-assisted radical prostatectomy: long-term results of a Canadian prospective cohort. Can Urol Assoc J. 2018. doi:10.5489/cuaj.5356
  • Tucci M, Leone G, Buttigliero C, et al. Hormonal treatment and quality of life of prostate cancer patients: new evidence. Minerva Urol Nefrol. 2018;70(2):144–151. doi:10.23736/S0393-2249.17.03066-129241313
  • Antonelli A, Palumbo C, Veccia A, et al. Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review. Minerva Urol Nefrol. 2018;70(4):370–379. doi:10.23736/S0393-2249.18.03022-929392925

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.